Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

GSK Investigational Site, New York

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Charlottesville

GSK Investigational Site, Chapel Hill

GSK Investigational Site, Charlotte

GSK Investigational Site, Jacksonville

GSK Investigational Site, Orlando

GSK Investigational Site, Miami

GSK Investigational Site, Deerfield Beach

GSK Investigational Site, Birmingham

GSK Investigational Site, Nashville

GSK Investigational Site, Germantown

GSK Investigational Site, Cleveland

GSK Investigational Site, Detroit

GSK Investigational Site, Rochester

GSK Investigational Site, Chicago

GSK Investigational Site, Covington

GSK Investigational Site, Oklahoma City

GSK Investigational Site, San Antonio

GSK Investigational Site, Phoenix

GSK Investigational Site, Scottsdale

GSK Investigational Site, Los Angeles

GSK Investigational Site, San Francisco

GSK Investigational Site, Stanford

GSK Investigational Site, Seattle

GSK Investigational Site, Boston

GSK Investigational Site, Boston

GSK Investigational Site, Boston

GSK Investigational Site, Burlington

GSK Investigational Site, Morristown